The Effects of Anti-infective Central Venous Catheter on Catheter-related Infection in Critically Patients

NCT02645682 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1818

Last updated 2017-05-10

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of anti-infective central venous catheter(Certofix®Protect) on reducing catheter-related bloodstream infection in critically ill patients in China, and the relationship between catheter-related bloodstream infection and catheter-related thrombosis.

Conditions

  • Critical Illness

Interventions

DEVICE

anti-infection CVC

DEVICE

normal CVC

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER
  • West China Hospital

    lead OTHER

Principal Investigators

  • Yan Kang, Doctor · West China Hospital

  • Bin Du, Doctor · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02645682 on ClinicalTrials.gov